Last update 21 Nov 2024

Tumour-infiltrating lymphocytes/central memory T cells therapy (Shanghai Biomed-union Biotechnology)

Overview

Basic Info

Drug Type
T-lymphocyte cell therapy
Synonyms
Adoptive TILTCM transfer therapy
Target-
Mechanism
Immunologic cytotoxicity, T lymphocyte replacements
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease
Active Indication
Pancreatic Cancer
Inactive Indication-
Originator Organization
Biomed Union Biotechnology Co., Ltd.Biomed Union Biotechnology Co., Ltd.
Active Organization
Biomed Union Biotechnology Co., Ltd.Biomed Union Biotechnology Co., Ltd.
Inactive Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Tumour-infiltrating lymphocytes/central memory T cells therapy (Shanghai Biomed-union Biotechnology)
NCT05438797 / RecruitingEarly Phase 1IIT
Clinical Study on the Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer
100 Clinical Results associated with Tumour-infiltrating lymphocytes/central memory T cells therapy (Shanghai Biomed-union Biotechnology)
Login to view more data
100 Translational Medicine associated with Tumour-infiltrating lymphocytes/central memory T cells therapy (Shanghai Biomed-union Biotechnology)
Login to view more data
100 Patents (Medical) associated with Tumour-infiltrating lymphocytes/central memory T cells therapy (Shanghai Biomed-union Biotechnology)
Login to view more data
100 Deals associated with Tumour-infiltrating lymphocytes/central memory T cells therapy (Shanghai Biomed-union Biotechnology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatic CancerPhase 1
CN
Biomed Union Biotechnology Co., Ltd.Biomed Union Biotechnology Co., Ltd.
02 Apr 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free